AUDIOEYE INC P1Y 0001362190--12-31 2026 Q1 false 12414000 12285000 1 0001362190 us-gaap:RetainedEarningsMember 2026-03-31 0001362190 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001362190 us-gaap:RetainedEarningsMember 2025-12-31 0001362190 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001362190 us-gaap:RetainedEarningsMember 2025-03-31 0001362190 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001362190 us-gaap:RetainedEarningsMember 2024-12-31 0001362190 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001362190 us-gaap:CommonStockMember 2026-03-31 0001362190 us-gaap:CommonStockMember 2025-12-31 0001362190 us-gaap:CommonStockMember 2025-03-31 0001362190 us-gaap:CommonStockMember 2024-12-31 0001362190 us-gaap:EmployeeStockOptionMember 2026-01-01 2026-03-31 0001362190 us-gaap:EmployeeStockOptionMember 2026-03-31 0001362190 us-gaap:EmployeeStockOptionMember 2025-12-31 0001362190 2022-05-31 0001362190 us-gaap:RestrictedStockUnitsRSUMember 2025-12-31 0001362190 us-gaap:RestrictedStockUnitsRSUMember 2026-01-01 2026-03-31 0001362190 us-gaap:RestrictedStockUnitsRSUMember 2026-03-31 0001362190 aeye:PartnerAndMarketplaceMember 2026-01-01 2026-03-31 0001362190 aeye:EnterpriseMember 2026-01-01 2026-03-31 0001362190 aeye:PartnerAndMarketplaceMember 2025-01-01 2025-03-31 0001362190 aeye:EnterpriseMember 2025-01-01 2025-03-31 0001362190 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001362190 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001362190 us-gaap:RevolvingCreditFacilityMember 2025-03-31 0001362190 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2026-03-31 0001362190 us-gaap:CustomerRelatedIntangibleAssetsMember 2026-03-31 0001362190 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2025-12-31 0001362190 us-gaap:CustomerRelatedIntangibleAssetsMember 2025-12-31 0001362190 us-gaap:RestrictedStockUnitsRSUMember 2026-03-31 0001362190 srt:MinimumMember 2026-01-01 2026-03-31 0001362190 srt:MaximumMember 2026-01-01 2026-03-31 0001362190 srt:MaximumMember aeye:TermLoanFacilityMember 2025-03-31 0001362190 aeye:TermLoanAdvanceMember 2025-03-31 0001362190 aeye:LoanAndSecurityAgreementWithSgCreditPartnersMember 2023-11-30 0001362190 us-gaap:RevolvingCreditFacilityMember 2026-03-31 0001362190 aeye:TermLoanAdvanceMember 2026-04-10 2026-04-10 0001362190 aeye:MajorCustomerNumberOneMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-03-31 0001362190 aeye:MajorCustomerNumberOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-03-31 0001362190 aeye:MajorCustomerNumberOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-12-31 0001362190 aeye:MajorCustomerNumberOneMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-03-31 0001362190 2025-03-31 0001362190 2024-12-31 0001362190 us-gaap:RestrictedStockUnitsRSUMember 2026-01-01 2026-03-31 0001362190 us-gaap:RestrictedStockUnitsRSUMember 2025-01-01 2025-03-31 0001362190 us-gaap:EmployeeStockOptionMember 2026-01-01 2026-03-31 0001362190 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001362190 us-gaap:EmployeeStockOptionMember 2025-01-01 2025-03-31 0001362190 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001362190 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001362190 2025-01-31 0001362190 aeye:KellyGeorgevichMember 2025-06-09 0001362190 aeye:DavidMoradiMember 2025-05-30 0001362190 aeye:KellyGeorgevichMember 2026-09-09 2026-09-09 0001362190 aeye:DavidMoradiMember 2026-05-29 2026-05-29 0001362190 aeye:KellyGeorgevichMember 2026-03-23 2026-03-23 0001362190 aeye:DavidMoradiMember 2026-03-12 2026-03-12 0001362190 aeye:KellyGeorgevichMember 2025-06-09 2025-06-09 0001362190 aeye:DavidMoradiMember 2025-05-30 2025-05-30 0001362190 2026-04-30 0001362190 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001362190 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001362190 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001362190 2022-05-01 2022-05-31 0001362190 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-03-31 0001362190 aeye:MajorCustomerNumberOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2026-03-31 0001362190 us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-03-31 0001362190 aeye:TermLoanAdvanceMember 2026-03-31 0001362190 srt:MaximumMember aeye:TermLoanAdvanceMember 2026-03-31 0001362190 srt:MaximumMember aeye:TermLoanAdvanceMember 2025-03-31 0001362190 aeye:LoanAndSecurityAgreementWithSgCreditPartnersMember us-gaap:BaseRateMember 2023-11-30 2023-11-30 0001362190 aeye:TermLoanFacilityMember 2025-03-31 2025-03-31 0001362190 aeye:LoanAndSecurityAgreementWithSgCreditPartnersMember 2025-03-31 2025-03-31 0001362190 srt:MinimumMember aeye:TermLoanFacilityMember 2026-01-01 2026-03-31 0001362190 srt:MaximumMember aeye:TermLoanFacilityMember 2026-01-01 2026-03-31 0001362190 aeye:TermLoanFacilityMember 2026-03-31 0001362190 aeye:TermLoanFacilityMember 2026-01-01 2026-03-31 0001362190 aeye:QuartersCommencingSeptember302026ThroughJune302027Member aeye:TermLoanFacilityMember 2026-01-01 2026-03-31 0001362190 aeye:ForPeriodAfterJune302027Member aeye:TermLoanFacilityMember 2026-01-01 2026-03-31 0001362190 aeye:TermLoanFacilityMember us-gaap:SecuredOvernightFinancingRateSofrMember 2025-03-31 2025-03-31 0001362190 us-gaap:FairValueInputsLevel3Member 2026-03-31 0001362190 us-gaap:FairValueInputsLevel3Member 2025-12-31 0001362190 2026-03-31 0001362190 2025-12-31 0001362190 2025-01-01 2025-03-31 0001362190 2026-01-01 2026-03-31 iso4217:USD xbrli:pure aeye:customer xbrli:shares iso4217:USD xbrli:shares aeye:segment

Table of Contents

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

​

☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

​

For the quarterly period ended March 31, 2026

or

​

☐ | TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

​

For the transition period from [ ] to [ ]

Commission File Number: 001-38640

​

AudioEye, Inc.

(Exact name of registrant as specified in its charter)

​

Delaware | ​ ​ ​ | 20-2939845
(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.)
5210 East Williams Circle, Suite 750, Tucson, Arizona |  | 85711
(Address of principal executive offices) |  | (Zip Code)

​

Registrant’s telephone number, including area code: 866-331-5324

Securities registered pursuant to Section 12(b) of the Act:

Title of each class | Trading Symbol(s) | Name of each exchange on which registered
Common Stock, par value $0.00001 per share | AEYE | The Nasdaq Capital Market

​

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the last 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

​

Large accelerated filer | ☐ | Accelerated filer | ☐
Non-accelerated filer | ☒ | Smaller reporting company | ☒
Emerging growth company | ☐ |  |

​

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of April 30, 2026, 12,438,294 shares of the registrant’s common stock were issued and outstanding.

​

​

Table of Contents

​

​

​ | ​ | ​
​ | ​ | Page
PART I | FINANCIAL INFORMATION | 1
​ | ​ | ​
Item 1. | Financial Statements | 1
​ | ​ | ​
​ | Consolidated Balance Sheets as of March 31, 2026 and December 31, 2025 (unaudited) | 2
​ | ​ | ​
​ | Consolidated Statements of Operations for the three months ended March 31, 2026 and 2025 (unaudited) | 3
​ | ​ | ​
​ | Consolidated Statements of Stockholders’ Equity for the three months ended March 31, 2026 and 2025 (unaudited) | 4
​ | ​ | ​
​ | Consolidated Statements of Cash Flows for the three months ended March 31, 2026 and 2025 (unaudited) | 5
​ | ​ | ​
​ | Notes to Consolidated Financial Statements (unaudited) | 6
​ | ​ | ​
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 15
​ | ​ | ​
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 21
​ | ​ | ​
Item 4. | Controls and Procedures | 21
​ | ​ | ​
PART II | OTHER INFORMATION | 22
​ | ​ | ​
Item 1. | Legal Proceedings | 22
​ | ​ | ​
Item 1A. | Risk Factors | 22
​ | ​ | ​
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 22
​ | ​ | ​
Item 5. | Other Information | 23
​ | ​ | ​
Item 6. | Exhibits | 24
​ | ​ | ​
SIGNATURES | ​ | 25

​

​

​

​

​

Table of Contents

PART I — FINANCIAL INFORMATION

Item 1. Financial Statements

The financial information set forth below with respect to the consolidated financial statements as of March 31, 2026 and December 31, 2025 and for the three-month periods ended March 31, 2026 and 2025 is unaudited. This financial information, in the opinion of our management, includes all adjustments consisting of normal recurring entries necessary for the fair presentation of such data. The results of operations for the three-month period ended March 31, 2026 are not necessarily indicative of results to be expected for any subsequent period. Our fiscal year end is December 31. The Company presents its unaudited consolidated financial statements, notes, and other financial information rounded to the nearest thousand United States Dollars (“U.S. Dollar”), except for per share data.

​

​

​

1

Table of Contents

AUDIOEYE, INC.

CONSOLIDATED BALANCE SHEETS

(unaudited)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ ​ ​ | March 31, | ​ ​ ​ | December 31, | ​ ​ ​
(in thousands, except per share data) | ​ | 2026 | ​ | 2025 | ​
ASSETS | ​ | ​ | ​ | ​ | ​ | ​ | ​
Current assets: |  | ​ | ​ |  | ​ | ​ |
Cash and cash equivalents | ​ | $ | 8,563 | ​ | $ | 5,288 | ​
Accounts receivable, net of allowance for doubtful accounts of $559 and $643, respectively | ​ |  | 6,294 | ​ |  | 6,557 | ​
Prepaid expenses and other current assets | ​ |  | 1,019 | ​ |  | 777 | ​
Total current assets | ​ |  | 15,876 | ​ |  | 12,622 | ​
​ | ​ |  | ​ | ​ |  | ​ | ​
Property and equipment, net of accumulated depreciation of $250 and $227, respectively | ​ |  | 137 | ​ |  | 146 | ​
Right of use assets | ​ | ​ | 324 | ​ | ​ | 168 | ​
Intangible assets, net of accumulated amortization of $14,237 and $13,251, respectively | ​ |  | 12,036 | ​ |  | 12,515 | ​
Goodwill | ​ | ​ | 6,682 | ​ | ​ | 6,682 | ​
Other | ​ |  | 45 | ​ |  | 97 | ​
Total assets | ​ | $ | 35,100 | ​ | $ | 32,230 | ​
​ | ​ |  | ​ | ​ |  | ​ | ​
LIABILITIES AND STOCKHOLDERS’ EQUITY | ​ |  | ​ | ​ |  | ​ | ​
Current liabilities: | ​ |  | ​ | ​ |  | ​ | ​
Accounts payable and accrued expenses | ​ | $ | 5,816 | ​ | $ | 4,851 | ​
Operating lease liabilities | ​ | ​ | 54 | ​ | ​ | 218 | ​
Deferred revenue | ​ |  | 8,491 | ​ |  | 8,619 | ​
Contingent consideration | ​ | ​ | 225 | ​ | ​ | 225 | ​
Term loan, current | ​ | ​ | 850 | ​ | ​ | 503 | ​
Total current liabilities | ​ |  | 15,436 | ​ |  | 14,416 | ​
​ | ​ |  | ​ | ​ |  | ​ | ​
Long term liabilities: | ​ |  | ​ | ​ |  | ​ | ​
Term loan, net | ​ | ​ | 15,756 | ​ | ​ | 12,479 | ​
Operating lease liabilities | ​ | ​ | 283 | ​ | ​ | — | ​
Deferred revenue | ​ |  | 7 | ​ |  | 5 | ​
Contingent consideration, long term | ​ |  | 300 | ​ |  | 300 | ​
Other | ​ | ​ | 139 | ​ | ​ | 226 | ​
Total liabilities | ​ |  | 31,921 | ​ |  | 27,426 | ​
​ | ​ |  | ​ | ​ |  | ​ | ​
Stockholders’ equity: | ​ |  | ​ | ​ |  | ​ | ​
Preferred stock, $0.00001 par value, 10,000 shares authorized | ​ |  | ​ | ​ |  | ​ | ​
Common stock, $0.00001 par value, 50,000 shares authorized, 12,430 and 12,383 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | ​ |  | 1 | ​ |  | 1 | ​
Additional paid-in capital | ​ |  | 109,165 | ​ |  | 108,201 | ​
Accumulated deficit | ​ |  | (105,987) | ​ |  | (103,398) | ​
Total stockholders’ equity | ​ |  | 3,179 | ​ |  | 4,804 | ​
​ | ​ |  | ​ | ​ |  | ​ | ​
Total liabilities and stockholders’ equity | ​ | $ | 35,100 | ​ | $ | 32,230 | ​

​

See Notes to Unaudited Consolidated Financial Statements

​

2

Table of Contents

AUDIOEYE, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three months ended March 31, | ​
(in thousands, except per share data) | ​ ​ ​ | 2026 | ​ ​ ​ | 2025 | ​ ​ ​
Revenue | ​ | $ | 10,553 | ​ | $ | 9,733 | ​
​ | ​ |  | ​ | ​ |  | ​ | ​
Cost of revenue | ​ |  | 2,301 | ​ |  | 1,995 | ​
​ | ​ |  | ​ | ​ |  | ​ | ​
Gross profit | ​ |  | 8,252 | ​ |  | 7,738 | ​
​ | ​ |  | ​ | ​ |  | ​ | ​
Operating expenses: | ​ |  | ​ | ​ |  | ​ | ​
Selling and marketing | ​ |  | 3,852 | ​ |  | 3,714 | ​
Research and development | ​ |  | 1,110 | ​ |  | 1,153 | ​
General and administrative | ​ |  | 5,173 | ​ |  | 3,761 | ​
Change in fair value of contingent consideration | ​ | ​ | — | ​ |  | 50 | ​
Total operating expenses | ​ |  | 10,135 | ​ |  | 8,678 | ​
​ | ​ |  | ​ | ​ |  | ​ | ​
Operating loss | ​ |  | (1,883) | ​ |  | (940) | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Other expense: | ​ |  | ​ | ​ |  | ​ | ​
Interest expense, net | ​ | ​ | (231) | ​ |  | (229) | ​
Loss on extinguishment of debt | ​ |  | — | ​ |  | (300) | ​
Total other expense | ​ | ​ | (231) | ​ | ​ | (529) | ​
​ | ​ |  | ​ | ​ |  | ​ | ​
Net loss | ​ | $ | (2,114) | ​ | $ | (1,469) | ​
​ | ​ |  | ​ | ​ |  | ​ | ​
Net loss per common share-basic and diluted | ​ | $ | (0.17) | ​ | $ | (0.12) | ​
​ | ​ |  | ​ | ​ |  | ​ | ​
Weighted average common shares outstanding-basic and diluted | ​ |  | 12,460 | ​ |  | 12,390 | ​

​

See Notes to Unaudited Consolidated Financial Statements

​

3

Table of Contents

AUDIOEYE, INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

THREE MONTHS ENDED MARCH 31, 2026 AND 2025

(unaudited)

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ ​ ​ | ​ ​ ​ | ​ ​ ​ | ​ ​ ​ | ​ | ​ ​ ​ | Additional | ​ ​ ​ | ​ | ​ | ​ ​ ​ | ​ | ​
​ | ​ | Common stock | ​ | Paid-in | ​ | Accumulated | ​ | ​ | ​
(in thousands) | ​ ​ ​ | Shares | ​ ​ ​ | Amount | ​ | Capital | ​ ​ ​ | Deficit | ​ ​ ​ | Total
Balance, December 31, 2025 |  | 12,383 | ​ | $ | 1 | ​ | $ | 108,201 | ​ | $ | (103,398) | ​ | $ | 4,804
Common stock issued upon settlement of restricted stock units | ​ | 169 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | —
Issuance of common stock for services | ​ | 4 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | —
Surrender of stock to cover tax liability on settlement of employee stock-based awards | ​ | (44) | ​ | ​ | — | ​ | ​ | (382) | ​ | ​ | — | ​ | ​ | (382)
Common stock repurchased for retirement | ​ | (82) | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (475) | ​ | ​ | (475)
Stock-based compensation | ​ | — | ​ | ​ | — | ​ | ​ | 1,346 | ​ | ​ | — | ​ | ​ | 1,346
Net loss |  | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (2,114) | ​ | ​ | (2,114)
Balance, March 31, 2026 | ​ | 12,430 | ​ | $ | 1 | ​ | $ | 109,165 | ​ | $ | (105,987) | ​ | $ | 3,179

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | Additional | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Common stock | ​ | Paid-in | ​ | Accumulated | ​ | ​ | ​
(in thousands) | ​ ​ ​ | Shares | ​ ​ ​ | Amount | ​ ​ ​ | Capital | ​ ​ ​ | Deficit | ​ ​ ​ | Total
Balance, December 31, 2024 | ​ | 12,285 | ​ | $ | 1 | ​ | $ | 105,181 | ​ | $ | (95,746) | ​ | $ | 9,436
Common stock issued upon settlement of restricted stock units | ​ | 207 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | —
Common stock issued upon exercise of options on a cash basis | ​ | 6 | ​ | ​ | — | ​ | ​ | 38 | ​ | ​ | — | ​ | ​ | 38
Issuance of common stock for services | ​ | 7 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | —
Surrender of stock to cover tax liability on settlement of employee stock-based awards | ​ | (60) | ​ | ​ | — | ​ | ​ | (966) | ​ | ​ | — | ​ | ​ | (966)
Stock-based compensation | ​ | — | ​ | ​ | — | ​ | ​ | 907 | ​ | ​ | — | ​ | ​ | 907
Net loss |  | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (1,469) | ​ | ​ | (1,469)
Balance, March 31, 2025 | ​ | 12,445 | ​ | $ | 1 | ​ | $ | 105,160 | ​ | $ | (97,215) | ​ | $ | 7,946

​

See Notes to Unaudited Consolidated Financial Statements

​

4

Table of Contents

AUDIOEYE, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three months ended March 31, | ​
(in thousands) | ​ ​ ​ | 2026 | ​ ​ ​ | 2025 | ​ ​ ​
CASH FLOWS FROM OPERATING ACTIVITIES: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net loss | ​ | $ | (2,114) | ​ | $ | (1,469) | ​
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Depreciation and amortization | ​ |  | 1,011 | ​ |  | 775 | ​
Loss on disposal or impairment of long-lived assets | ​ | ​ | — | ​ | ​ | 40 | ​
Loss on extinguishment of debt | ​ | ​ | — | ​ | ​ | 300 | ​
Stock-based compensation expense | ​ | ​ | 1,346 | ​ | ​ | 907 | ​
Amortization of deferred commissions | ​ | ​ | 11 | ​ | ​ | 9 | ​
Amortization of debt discount and issuance costs | ​ |  | 24 | ​ |  | 23 | ​
Amortization of right-of-use assets | ​ | ​ | 56 | ​ | ​ | 45 | ​
Change in fair value of contingent consideration | ​ |  | — | ​ |  | 50 | ​
Provision for accounts receivable | ​ | ​ | 52 | ​ | ​ | 140 | ​
Changes in operating assets and liabilities: | ​ | ​ | ​ | ​ | ​ | ​ | ​
Accounts receivable | ​ | ​ | 232 | ​ | ​ | (558) | ​
Prepaid expenses and other assets | ​ | ​ | (187) | ​ | ​ | (240) | ​
Accounts payable and accruals | ​ |  | 1,010 | ​ |  | (22) | ​
Operating lease liability | ​ |  | (55) | ​ |  | (48) | ​
Deferred revenue | ​ |  | (126) | ​ |  | 4 | ​
Net cash provided by (used in) operating activities | ​ |  | 1,260 | ​ |  | (44) | ​
​ | ​ |  | ​ | ​ | ​ | ​ | ​
CASH FLOWS FROM INVESTING ACTIVITIES: | ​ |  | ​ | ​ | ​ | ​ | ​
Purchase of equipment | ​ |  | (17) | ​ |  | (3) | ​
Software development costs | ​ |  | (465) | ​ |  | (472) | ​
Patent costs | ​ | ​ | — | ​ | ​ | (4) | ​
Payment for acquisitions, net | ​ | ​ | (245) | ​ | ​ | (311) | ​
Net cash used in investing activities | ​ |  | (727) | ​ |  | (790) | ​
​ | ​ |  | ​ | ​ | ​ | ​ | ​
CASH FLOWS FROM FINANCING ACTIVITIES: | ​ |  | ​ | ​ | ​ | ​ | ​
Proceeds from term loan, net of lender fees | ​ | ​ | 3,599 | ​ | ​ | 11,950 | ​
Payments for costs directly attributable to the issuance of term loan | ​ | ​ | — | ​ | ​ | (325) | ​
Repayment of term loan | ​ | ​ | — | ​ | ​ | (7,000) | ​
Payments for debt extinguishment costs | ​ | ​ | — | ​ | ​ | (249) | ​
Proceeds from exercise of options | ​ | ​ | — | ​ | ​ | 38 | ​
Payments related to settlement of employee shared-based awards | ​ | ​ | (382) | ​ | ​ | (966) | ​
Repurchase of common stock | ​ | ​ | (475) | ​ | ​ | — | ​
Net cash provided by financing activities | ​ |  | 2,742 | ​ |  | 3,448 | ​
​ | ​ |  | ​ | ​ | ​ | ​ | ​
Net increase in cash and cash equivalents | ​ |  | 3,275 | ​ |  | 2,614 | ​
Cash and cash equivalents - beginning of period | ​ |  | 5,288 | ​ |  | 5,651 | ​
Cash and cash equivalents - end of period | ​ | $ | 8,563 | ​ | $ | 8,265 | ​

​

See Notes to Unaudited Consolidated Financial Statements

​

​

5

Table of Contents

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2026

(Unaudited)

NOTE 1 — BASIS OF PRESENTATION

The accompanying unaudited interim consolidated financial statements of AudioEye, Inc. and its wholly-owned subsidiaries, ADA Site Compliance, LLC, Criterion 508 Solutions, Inc., Ability, Inc., and Equally AI Ltd. (“we”, “our” or the “Company”), have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP” or “GAAP”) and the rules of the Securities and Exchange Commission (the “SEC”), and should be read in conjunction with the audited consolidated financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “2025 Form 10-K”), as filed with the SEC on March 12, 2026. Subsequent to March 31, 2026, each of ADA Site Compliance, LLC, Criterion 508 Solutions, Inc., and Ability, Inc. was merged into AudioEye, Inc.

In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. Certain information and disclosures normally contained in the audited consolidated financial statements as reported in the Company’s Annual Report on Form 10-K have been condensed or omitted in accordance with the SEC’s rules and regulations for interim reporting.

​

NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Our significant accounting policies are presented in “Note 2 – Significant Accounting Policies” in the 2025 Form 10-K. Users of financial information for interim periods are encouraged to refer to the footnotes to the consolidated financial statements contained in the 2025 Form 10-K when reviewing interim financial results.

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the consolidated financial statements and during the reporting period. On an ongoing basis, management evaluates its estimates and judgments, including those related to stock-based compensation, allowance for doubtful accounts, intangible assets, and contingent consideration. Actual results may differ from these estimates.

Revenue Recognition

We derive our revenue primarily from the sale of internally developed software by a software-as-a-service (“SaaS”) delivery model, as well as from professional services, through our direct sales force or through third-party resellers. Our SaaS fees include support and maintenance.

We recognize revenue in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers (“ASC 606”). The core principle of ASC 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.

We determine revenue recognition through the following five steps:

| ● | Identify the contract with the customer;

| ● | Identify the performance obligations in the contract;

| ● | Determine the transaction price;

| ● | Allocate the transaction price to the performance obligations in the contract; and

6

Table of Contents

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2026

(Unaudited)

| ● | Recognize revenue when, or as, the performance obligations are satisfied.

Performance obligations are the unit of accounting for revenue recognition and generally represent the distinct goods or services that are promised to the customer.

Our SaaS revenue is comprised of fixed subscription fees from customer accounts on our platform related to our software products. Our support revenue is comprised of subscription fees for customers for periodic auditing, human-assisted technological remediations, legal support, and other professional support services. SaaS and support (also referred to as “subscription”) revenue is recognized on a ratable basis over the contractual subscription term of the arrangement beginning on the date that our service is made available to the customer. Certain SaaS and support fees are invoiced in advance on an annual, semi-annual, or quarterly basis. Any funds received for services not provided yet are held in deferred revenue and are recorded as revenue when the related performance obligations have been satisfied. Our subscription agreements are generally non-cancelable, although clients typically have the right to terminate their contracts for cause if we fail to perform material obligations.

Non-subscription revenue consists primarily of PDF remediation and one-time website and mobile application reporting services and is recognized upon delivery. Consideration payable under PDF remediation arrangements is based on usage. Consideration payable under non-subscription website and mobile application reporting services arrangements is based on fixed fees.

The following tables present our revenues disaggregated by sales channel:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three months ended March 31, | ​
(in thousands) | ​ ​ ​ | 2026 | ​ ​ ​ | 2025 | ​
Partner and Marketplace | ​ | $ | 5,971 |  | $ | 5,520 | ​
Enterprise | ​ |  | 4,582 | ​ | ​ | 4,213 | ​
Total revenues | ​ | $ | 10,553 | ​ | $ | 9,733 | ​

​

The Company records accounts receivable for amounts invoiced to customers for which the Company has an unconditional right to consideration as provided under the contractual arrangement. Deferred revenue includes payments received in advance of performance under the contract and is reported on an individual contract basis at the end of each reporting period. Deferred revenue is classified as current or noncurrent based on the timing of when we expect to recognize revenue.

The table below summarizes our deferred revenue as of March 31, 2026 and December 31, 2025:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | March 31, | ​ | December 31, | ​
(in thousands) | ​ ​ ​ | 2026 | ​ ​ ​ | 2025 | ​
Deferred revenue – current | ​ | $ | 8,491 | ​ | $ | 8,619 | ​
Deferred revenue – noncurrent | ​ | ​ | 7 | ​ | ​ | 5 | ​
Total deferred revenue | ​ | $ | 8,498 |  | $ | 8,624 | ​

​

In the three-month period ended March 31, 2026, we recognized $4,074,000, or 47%, in revenue from deferred revenue outstanding as of December 31, 2025.

We had one customer (including the customer’s affiliates reflecting multiple contracts and a partnership with the Company) which accounted for approximately 13% and 14% of our total revenue in the three months ended March 31, 2026 and 2025, respectively.

As of March 31, 2026 and December 31, 2025, one customer represented 13% and 12% of total accounts receivable, respectively.

Deferred Costs (Contract Acquisition Costs)

We capitalize initial and renewal sales commissions in the period the commission is earned, which generally occurs when a customer contract is obtained, and amortize deferred commission costs on a straight-line basis over the expected period of benefit, which we have

7

Table of Contents

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2026

(Unaudited)

deemed to be the contract term. As a practical expedient, we expense sales commissions as incurred when the amortization period of related deferred commission costs would have been one year or less.

The table below summarizes the deferred commission costs as of March 31, 2026 and December 31, 2025, which are included in Prepaid expenses and other current assets (current portion) and Other assets (noncurrent portion) on our consolidated balance sheets:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | March 31, | ​ | December 31, |
(in thousands) | ​ ​ ​ | 2026 | ​ ​ ​ | 2025 | ​
Deferred costs – current | ​ | $ | 36 | ​ | $ | 39 | ​
Deferred costs – noncurrent | ​ |  | 27 | ​ |  | 29 | ​
Total deferred costs | ​ | $ | 63 | ​ | $ | 68 | ​

​

Amortization expense associated with sales commissions was included in Selling and marketing expenses on the consolidated statements of operations and totaled $11,000 and $9,000 for the three months ended March 31, 2026 and 2025, respectively.

Business Combinations

The assets acquired, liabilities assumed and contingent consideration in business combinations are recorded at their estimated fair value on the acquisition date with subsequent changes recognized in earnings. These estimates are inherently uncertain and are subject to refinement. Management develops estimates based on assumptions as part of the purchase price allocation process to value the assets acquired and liabilities assumed as of the business combination date. As a result, the Company may recognize adjustments to provisional amounts of assets acquired or liabilities assumed in earnings in the reporting period in which the adjustments are determined.

Acquisition-related expenses primarily consist of legal, accounting, and other advisory fees and are recorded in the period in which they are incurred.

Asset Acquisitions

Acquisitions that do not meet the definition of a business are accounted for as asset acquisitions. The Company allocates the cost of the acquisition to the individual assets acquired and liabilities assumed on a relative fair value basis and goodwill is not recognized in an asset acquisition. Contingent consideration is not recorded in an asset acquisition until it is deemed probable and reasonably estimable. Direct transaction costs are capitalized as a component of the cost of the acquisition.

Intangible Assets

Intangible assets include patents, capitalized software development costs, and customer relationships. Intangible assets with finite lives are amortized on a straight-line basis over their respective estimated useful lives and are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Intangible assets determined to have indefinite useful lives are not amortized but are tested for impairment annually and more frequently if events occur or circumstances change that indicate an asset may be impaired.

As of March 31, 2026 and December 31, 2025, intangible assets primarily included $8,897,000 and $9,334,000 in customer relationships, respectively, and $2,994,000 and $3,028,000 in capitalized software development costs, respectively, net of accumulated amortization.

Debt Discount and Debt Issuance Costs

Costs related to the issuance of debt due to the lender (debt discount) or to third parties (debt issuance costs) are capitalized and amortized to interest expense over the term of the related debt on a straight-line basis, which is not materially different from the effective interest method. Debt discount and debt issuance costs are presented on the Company’s consolidated balance sheets as a direct deduction from the carrying amount of our term loan.

8

Table of Contents

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2026

(Unaudited)

Employee Stock Purchase Plan

In May 2022, the stockholders of the Company approved the Company’s Employee Stock Purchase Plan (the “ESPP”), which provides for the issuance of up to 500,000 shares of common stock. Eligible employees may elect to have a percentage of eligible compensation withheld to purchase shares of our common stock at the end of each purchase period. The Company expects each purchase period to be the six-month periods ending on June 30 or December 31 of each calendar year. T he purchase price per share equals 85% of the fair market value of our common stock on the first trading day or the last trading day of each purchase period, whichever amount is lower. Accordingly, the fair value of shares of common stock to be issued under the ESPP is measured on the first day of each offering period using a Black-Scholes option pricing model.

Under the ESPP, a participant may not be granted rights to purchase more than $25,000 worth of common stock for each calendar year and no participant may purchase more than 1,500 shares of our common stock (or such other number as the Compensation Committee may designate) on any one purchase date. As of March 31, 2026, 31,543 shares had been issued under the ESPP and 468,457 shares remained available under the plan.

Stock-Based Compensation

The Company periodically issues options, restricted stock units (“RSUs”), and shares of its common stock as compensation for services received from its employees, directors, and consultants. The fair value of the award is measured on the grant date. The fair value amount is then recognized as expense over the requisite vesting period during which services are required to be provided in exchange for the award. We recognize forfeitures as they occur. Stock-based compensation expense is recorded in the same expense classifications in the consolidated statements of operations as if such amounts were paid in cash.

The fair value of option awards is measured on the grant date using a Black-Scholes option pricing model, which includes assumptions that are subjective and are generally derived from external data (such as risk-free rate of interest) and historical data (such as volatility factor and expected term).

We estimate the fair value of restricted stock unit awards with time- or performance-based vesting using the value of our common stock on the grant date. We estimate the fair value of market-based restricted stock unit awards as of the grant date using the Monte Carlo simulation model.

We expense the compensation cost associated with time-based options and RSUs as the restriction period lapses, which is typically a one- to three-year service period with the Company. Compensation expense related to performance-based RSUs is recognized on a straight-line basis over the requisite service period, provided that it is probable that performance conditions will be achieved, with probability assessed on a quarterly basis and any changes in expectations recognized as an adjustment to earnings in the period of the change. Compensation cost is not recognized for service- and performance-based awards that do not vest because service or performance conditions are not satisfied, and any previously recognized compensation cost is reversed. Compensation costs related to awards with market conditions are recognized on a straight-line basis over the requisite service period regardless of whether the market condition is satisfied and is not reversed provided that the requisite service period derived from the Monte-Carlo simulation has been completed. If vesting occurs prior to the end of the requisite service period, expense is accelerated and fully recognized through the vesting date.

The following table summarizes the stock-based compensation expense recorded for the three months ended March 31, 2026 and 2025:

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three months ended March 31,
(in thousands) | ​ ​ ​ | 2026 | ​ ​ ​ | 2025
RSUs | ​ | $ | 1,316 | ​ | $ | 857
Unrestricted shares of common stock | ​ | ​ | 30 | ​ | ​ | 50
Total | ​ | $ | 1,346 | ​ | $ | 907

​

As of March 31, 2026, the unrecognized stock-based compensation expense related to outstanding RSUs totaled $3,535,000, which may be recognized through February 2028, subject to achievement of service, performance, and market conditions.

9

Table of Contents

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2026

(Unaudited)

​

The following table summarizes the stock option and RSUs activity for the three months ended March 31, 2026:

​

​ | ​ | ​ | ​ | ​
​ | ​ ​ ​ | Options | ​ ​ ​ | RSUs
Outstanding at December 31, 2025 |  | 7,436 |  | 988,767
Granted |  | — |  | 22,258
Exercised/Settled |  | — |  | (168,868)
Forfeited/Expired |  | (1,715) |  | (13,642)
Outstanding at March 31, 2026 |  | 5,721 |  | 828,515
Vested at March 31, 2026 | ​ | 5,721 | ​ | 304,637
Unvested at March 31, 2026 | ​ | — | ​ | 523,878

​

Earnings (Loss) Per Share (“EPS”)

Basic EPS is calculated by dividing net income (loss) available to common stockholders by the weighted average number of shares of the Company’s common stock outstanding during the period. Diluted EPS is calculated based on the net income (loss) available to common stockholders and the weighted average number of shares of common stock outstanding during the period, adjusted for the effects of all potential dilutive common stock issuances related to options and restricted stock units. The dilutive effect of our stock-based awards is computed using the treasury stock method, which assumes all stock-based awards are exercised and the hypothetical proceeds from exercise are used to purchase common stock at the average market price during the period. The incremental shares (i.e., the difference between shares assumed to be issued versus purchased), to the extent they would have been dilutive, are included in the denominator of the diluted EPS calculation. However, when a net loss exists, no potential common stock equivalents are included in the computation of the diluted per-share amount because the computation would result in an anti-dilutive per-share amount.

Potentially dilutive securities outstanding as of March 31, 2026 and 2025, which were excluded from the computation of basic and diluted net loss per share for the periods then ended, are as follows:

​

​ | ​ | ​ | ​ | ​ | ​
​ | ​ | March 31, | ​
(in thousands) | ​ ​ ​ | 2026 | ​ ​ ​ | 2025 | ​
Options |  | 6 |  | 28 | ​
Restricted stock units |  | 829 |  | 1,226 |
Total |  | 835 |  | 1,254 |

​

Stock Repurchases

In January 2025, the Board of Directors adopted a share repurchase program authorizing the repurchase of up to $12.5 million of our common stock through January 24, 2027. The program may be amended, suspended, or discontinued at any time and does not commit the Company to repurchase any shares of its common stock. In the three months ended March 31, 2026 and 2025, we used $475,000 and zero of the program to repurchase shares, respectively. As of March 31, 2026, we had $7.45 million remaining for the repurchase of shares.

Shares repurchased by the Company are immediately retired. The Company made an accounting policy election to charge the excess of repurchase price over par value entirely to retained earnings.

Fair Value of Financial Instruments

Fair value is an estimate of the exit price, representing the amount that would be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants (i.e., the exit price at the measurement date). Fair value measurements are based upon observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our view of market participant assumptions in the absence of observable market information. Assets and liabilities required to be measured at fair value are categorized based upon the level of judgment associated with the inputs used to measure their value in one of the following three categories:

10

Table of Contents

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2026

(Unaudited)

Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities.

Level 2: Inputs other than quoted market prices that are observable, either directly or indirectly, and reasonably available. Observable inputs reflect the assumptions market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the Company.

Level 3: Unobservable inputs reflect the assumptions that the Company develops based on available information about what market participants would use in valuing the asset or liability.

The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses approximate fair value based on the short-term maturity of these instruments.

The table below provides information on our Level 3 liabilities:

​

​ | ​ | ​ | ​
​ | ​ ​ ​ | Three Months Ended
(in thousands) | ​ | March 31, 2026
Contingent consideration (1) | ​ | ​ | Level 3
Balance at December 31, 2025 | ​ | $ | 525
Additions | ​ | ​ | —
Change in fair value of contingent consideration | ​ | ​ | —
Balance at March 31, 2026 | ​ | $ | 525

| (1) | Represents the value of the contingent consideration liability recorded in connection with asset acquisitions in 2025. The fair value of the contingent consideration was determined by management based on estimated recurring revenue from acquired customer relationships.

Recent Accounting Pronouncements

Recently Adopted

​

In July 2025, Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2025-05, Measurement of Credit Losses for Accounts Receivable and Contract Assets, which provides a practical expedient to measure credit losses on accounts receivable and contract assets. Under the practical expedient, entities may assume that current conditions as of the balance sheet date remain unchanged for the remaining life of the asset when developing reasonable and supportable forecasts. This ASU is effective for annual periods beginning after December 15, 2025, and interim periods within those annual reporting periods. The Company adopted this ASU beginning with the three months ended March 31, 2026, on a prospective basis. The adoption of ASU 2025-05 did not have a significant impact on the Company's consolidated financial statements.

​

Not Yet Adopted

​

In September 2025, the FASB issued ASU 2025-06, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software, which modernizes the recognition and disclosure framework for internal-use software costs, removing the previous “development stage” model and introducing a more judgment-based approach. ASU 2025-06 is effective for fiscal years beginning after December 15, 2027, and for interim periods within those annual reporting periods, with early adoption permitted. The Company is currently evaluating the impact of ASU 2025-06 on its consolidated financial statements and related disclosures.

​

In November 2024, the FASB issued ASU 2024-03, Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40) to improve the disclosures about a public entity’s expenses and provide more detailed information about the types of expenses included in certain expense captions in the consolidated financial statements. The amendments in this update are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15,

11

Table of Contents

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2026

(Unaudited)

2027. Early adoption is permitted and the amendments in this update should be applied either prospectively to financial statements issued for reporting periods after the effective date of this update or retrospectively to any or all prior periods presented in the financial statements. The Company is evaluating the impact of the new standard on the disclosures in its consolidated financial statements.

​

NOTE 3 — DEBT

​

Term Loan and Revolving Credit Facility with Western Alliance Bank

On March 31, 2025, the Company entered into a Loan and Security Agreement (the “Credit Facility Agreement”) with Western Alliance Bank, an Arizona corporation (the “Lender”). The Credit Facility Agreement provides for borrowings of up to $20.0 million, including (i) a term loan facility, comprising of a $12.0 million term loan advance funded on March 31, 2025, and subsequent term loan advances at the Company’s request through March 31, 2026, with an aggregate principal amount not to exceed $5.0 million (the “Term Advances”); and (ii) a revolving line of credit in an aggregate outstanding amount not to exceed $3.0 million (the “Revolving Facility”). The Term Advances and the Revolving Facility have a maturity date of March 31, 2030. In the three months ended March 31, 2026, we drew the remaining $3.6 million from the $5.0 million available as subsequent Term Advances, resulting in a total $17.0 million drawn under the term loan as of March 31, 2026.

The outstanding Term Advances and the Revolving Facility bear interest on the outstanding daily balance at a floating rate equal to 3.25% above the term SOFR rate, which is defined as the greater of (i) 2.30% and (ii) the 1-month Term SOFR Reference Rate.

For each Term Advance, the Company is obligated to pay interest-only payments with respect to such Term Advance through April 9, 2026. Beginning on April 10, 2026, the Company shall repay each outstanding Term Advance in (i) quarterly principal payments in the amount of 1.25% of the aggregate principal amount of Term Advances outstanding as of April 10, 2026, payable on the tenth (10th) day of each calendar quarter, plus (ii) monthly payments of accrued interest, payable on the tenth (10th) day of each month. The final payment for each Term Advance, due on March 31, 2030, shall include all outstanding principal and accrued and unpaid interest under such Term Advance. Once repaid, the Term Advances may not be reborrowed. The interest on the Revolving Facility is payable monthly with the principal outstanding amount due at maturity.

​

The Company incurred $50,000 in facility fees on the closing date, which were recorded as debt discount. The Company also incurred $443,000 in third-party expenses in connection with the term loan, which were recorded as debt issuance costs. Debt discount and debt issuance costs are presented as a direct deduction from the carrying amount of our term loan and are amortized to interest expense over the term of the loan on a straight-line basis, which is not materially different from the effective interest method.

In the three months ended March 31, 2026, amortization of debt discount and debt issuance costs (associated with the Western Alliance Bank credit facility) totaled $3,000 and $22,000, respectively.

The Credit Facility Agreement is secured by substantially all of our assets and contains certain customary financial covenants, including the requirements that the Company maintain at all times from the closing date through and including the calendar quarter ended June 30, 2026, (a) unrestricted and unencumbered cash held in accounts with the Lender equal to at least $3.0 million measured as of the last day of each calendar month, and (b) a ratio of certain total committed debt to its Annual Recurring Revenue between 0.70 to 0.55, depending on the testing date, measured as of the last day of each calendar quarter. During the period of time commencing on September 30, 2026, and continuing through and including March 31, 2030, the Company shall maintain (a) a ratio of its aggregate funded indebtedness to its adjusted EBITDA for the prior twelve months of no greater than (i) 2.50 to 1.00 for the calendar quarters commencing September 30, 2026 through and including June 30, 2027, and (ii) 2.00 to 1.00 at all times thereafter, in each case measured as of the last day of each calendar quarter, and (b) a Fixed Charge Coverage Ratio of at least 1.50 to 1.00.

​

As of March 31, 2026, the outstanding principal balance of our term loan totaled $17.0 million and there were no outstanding borrowings under the revolving line of credit. As of March 31, 2026, revolving line of credit available for future draws totaled $3.0 million.

​

12

Table of Contents

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2026

(Unaudited)

​

As of March 31, 2026, future principal payments of debt based on the principal balance then outstanding are as follows (in thousands):

​

​ | ​ | ​ | ​
Year ending December 31, | ​ | Term Loan
2026 (9 months remaining) | ​ | $ | 638
2027 | ​ | ​ | 850
2028 | ​ | ​ | 850
2029 | ​ | ​ | 850
2030 | ​ | ​ | 13,812
Total repayments | ​ | $ | 17,000

​

As of March 31, 2026, the $17,000,000 in future principal payments reconciles to the carrying value on the consolidated balance sheet as follows:

​

​ | ​ | ​ | ​
(in thousands) | ​ | March 31, 2026
Term loan principal | ​ | $ | 17,000
Less: unamortized debt discount and debt issuance costs | ​ | ​ | (394)
Term loan, net | ​ | $ | 16,606
Term loan, current | ​ | $ | 850
Term loan, noncurrent | ​ | $ | 15,756

​

Term Loan with SG Credit Partners

​

On November 30, 2023, the Company entered into a Loan and Security Agreement (the “Loan Agreement”) with SG Credit Partners, Inc., a Delaware corporation. The Loan Agreement provided for a $7.0 million term loan, which was due and payable on the maturity date of November 30, 2026. The interest rate was 6.25% in excess of the base rate, which is defined as the greater of the prime rate and 7.00% per annum. Interest was payable in cash on a monthly basis.

On March 31, 2025, the Company paid $7.0 million in outstanding principal, $105,000 in exit fees and $144,000 in prepayment and other fees with the proceeds from the Credit Facility Agreement to repay in full all indebtedness, liabilities and other obligations outstanding under, and terminated, the Loan Agreement. In the three months ended March 31, 2025, we recognized a $300,000 loss on extinguishment of debt in connection with the termination of the term loan under the Loan Agreement, which included the unamortized portion of related debt discount and debt issuance costs.

NOTE 4 — COMMITMENTS AND CONTINGENCIES

Litigation

We may become involved in various routine disputes and allegations incidental to our business operations. While it is not possible to determine the ultimate disposition of these matters, management believes that the resolution of any such matters, should they arise, is not likely to have a material adverse effect on our financial position or results of operations.

​

Contingent Consideration

​

The Company recorded contingent consideration liabilities in connection with certain transactions accounted for as asset acquisitions as they do not meet the definition of a business. The fair value of the contingent consideration liabilities was determined by management based on estimated recurring revenue from acquired customer relationships. As of March 31, 2026, total contingent consideration was $525,000.

​

13

Table of Contents

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2026

(Unaudited)

Operating Leases

The Company has operating leases for office space in Tucson, Arizona, and Miami Beach, Florida. The following summarizes the total lease liabilities and remaining future minimum lease payments as of March 31, 2026 (in thousands):

​

​ | ​ | ​ | ​
Year ending December 31, | ​ | Operating Leases
2026 (9 months remaining) | ​ | $ | 58
2027 | ​ | ​ | 80
2028 | ​ | ​ | 83
2029 | ​ | ​ | 85
2030 | ​ | ​ | 88
Thereafter | ​ | ​ | 15
Total minimum lease payments | ​ |  | 409
Less: present value discount | ​ |  | (72)
Total lease liabilities | ​ | $ | 337
Current portion of lease liabilities | ​ | $ | 54
Long term portion of lease liabilities | ​ | $ | 283

​

​

NOTE 5 — SEGMENT INFORMATION

​

The Company has a single reportable segment focused around the sale of similar products and related services. This reportable segment derives revenues from customers by selling subscriptions for our digital accessibility platform delivering website accessibility compliance and providing services related to digital accessibility.

The Company’s chief operating decision-maker (the "CODM”), who is the chief executive officer, assesses performance for the reportable segment and decides how to allocate resources using net income as the primary measure of profitability. The CODM is not regularly provided with specific segment expenses, but focuses on revenue, gross margin, and net income. Expense information, including cost of revenue, can be easily computed from the provided information. These segment measures of profitability are shown in the consolidated statements of operations. The measure of segment assets is reported on the consolidated balance sheets as total assets.

​

NOTE 6 — SUBSEQUENT EVENTS

We have evaluated subsequent events occurring after March 31, 2026, and based on our evaluation we did not identify any events that would have required recognition or disclosure in these consolidated financial statements.

​

14

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations, or MD&A, should be read in conjunction with our consolidated financial statements and related notes in Part I, Item 1 of this report.

As used in this quarterly report, the terms “we,” “us,” “our” and similar references refer to AudioEye, Inc., unless otherwise indicated.

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). In some cases, you may be able to identify forward-looking statements by terms such as “may,” “should,” “will,” “forecasts,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “projects,” “potential” or “continue,” the negative of these terms and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements relate to our future plans, objectives, expectations, intentions and financial performance and the assumptions that underlie these statements, and are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions and speak only as of the date on which they are made.

Because these forward-looking statements involve known and unknown risks and uncertainties, there are important factors that could cause actual results, events or developments to differ materially from those expressed or implied by these forward-looking statements, including our plans, objectives, expectations and intentions and other factors discussed in “Part I, Item 1A. Risk Factors” contained in our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q. Risk factors that could cause actual results to differ from those contained in the forward-looking statements include but are not limited to risks related to:

| ● | the uncertain market acceptance of our existing and future products;

| ● | our need for, and the availability of, additional capital in the future to fund our operations and the development of new products;

| ● | the success, timing and financial consequences of new strategic relationships, acquisitions or licensing agreements we may enter into;

| ● | rapid changes in Internet-based applications that may affect the utility and commercial viability of our products;

| ● | the timing and magnitude of expenditures we may incur in connection with our ongoing product development activities;

| ● | judicial applications of accessibility laws to the internet;

| ● | the level of competition from our existing competitors and from new competitors in our marketplace; and

| ● | the regulatory environment for our products and services.

Readers of this report are cautioned not to rely on these forward-looking statements, since there can be no assurance that these forward-looking statements will prove to be accurate. Forward-looking statements speak only as of the date they are made, and we expressly disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You are advised, however, to consult any further disclosures we make on related subjects in our subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. This cautionary note is applicable to all forward-looking statements contained in this report.

15

Table of Contents

AudioEye Solutions

At its core, AudioEye’s offering provides ongoing testing, automated fixes, and 24/7 monitoring that continually improves conformance with Web Content Accessibility Guidelines (“WCAG”). This in turn helps businesses and organizations comply with WCAG standards as well as applicable U.S. and foreign accessibility laws. Our technology is capable of immediately identifying and fixing most of the common accessibility errors and addresses a wide range of disabilities including dyslexia, color blindness, epilepsy and more. AudioEye also offers additional solutions to provide for enhanced compliance and accessibility, including periodic auditing, custom fixes by experts, and legal support services. Our solutions may be purchased through a subscription service on a month-to-month basis or with one or multi-year terms. We also offer PDF remediation services and mobile application and audit reporting services to help our customers with their digital accessibility needs.

Intellectual Property

Our intellectual property is primarily comprised of copyrights, trademarks, trade secrets, issued patents and pending patent applications. We have a patent portfolio comprised of twenty-six (26) issued patents in the United States and three (3) pending US patent applications. The commercial value of these patents is unknown.

We plan to continue to invest in research and development and expand our portfolio of proprietary intellectual property.

Our Annual Report filed on Form 10-K for the year ended December 31, 2025 as filed with the SEC on March 12, 2026 provides additional information about our business and operations.

Executive Overview

AudioEye is an industry-leading digital accessibility platform delivering Americans with Disabilities Act (“ADA”) and WCAG compliance at scale. Our solutions advance accessibility with patented technology that reduces barriers, expands access for individuals with disabilities, and enhances the user experience for a broader audience. In the three months ended March 31, 2026, we continued to focus on product innovation and expanding revenue.

We have two sales channels to deliver our product, the Partner and Marketplace channel and the Enterprise channel. AudioEye continues to focus on recurring revenue growth in both channels, while still offering our website and mobile application reporting services and PDF remediation services that provide non-recurring revenue.

In the three months ended March 31, 2026, total revenue increased by 8% over the prior year comparable period. As of March 31, 2026, Annual Recurring Revenue (“ARR”) was approximately $41.2 million, which represented an increase of 11% year-over-year. Refer to “Other Key Operating Metrics” below for details on how we calculate ARR.

As of March 31, 2026, AudioEye had approximately 127,000 customers, a 7% increase from 119,000 customers at March 31, 2025. The increase in customer count was attributable to an increase in our Partner and Marketplace channel customers.

In the three months ended March 31, 2026, revenue from our Partner and Marketplace channel grew 8% over the prior year comparable period. The Partner and Marketplace channel represented about 59% of ARR as of March 31, 2026. In three months ended March 31, 2026, total Enterprise channel revenue grew 9% over the prior year comparable period. The Enterprise channel represented about 41% of ARR as of March 31, 2026.

We had one customer (including the customer’s affiliates reflecting multiple contracts and a partnership with the Company) which accounted for approximately 13% and 14% of our total revenue in the three months ended March 31, 2026 and 2025, respectively.

The Company continued to invest in research and development in the first quarter of 2026. Total research and development cost, as defined under the “Research and Development Expenses” section in the “Results of Operations” below, was 15% of total revenue in the three months ended March 31, 2026. Total research and development cost in the three months ended March 31, 2026 decreased from the prior year comparable period due to lower personnel cost.

In the three months ended March 31, 2026, both selling and marketing expense and general and administrative expense increased from the prior year comparable period. The increase in selling and marketing expense was mainly driven by higher third-party marketing

16

Table of Contents

expenses and personnel costs. The increase in general and administrative expenses in the three months ended March 31, 2026 was due primarily to higher litigation, stock compensation and amortization expense.

We provide further commentary on our Results of Operations below.

Results of Operations

Our unaudited consolidated financial statements are stated in United States Dollars and are prepared in accordance with United States Generally Accepted Accounting Principles (“U.S. GAAP” or “GAAP”). The discussion of the results of our operations compares the three months ended March 31, 2026 with the three months ended March 31, 2025.

Our results of operations in these interim periods are not necessarily indicative of the results which may be expected for any subsequent period. Due to rounding, numbers presented throughout this document may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures.

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three months ended March 31, | ​ | Change |
(in thousands) | ​ ​ ​ | 2026 | ​ ​ ​ | 2025 | ​ ​ ​ | $ | ​ ​ ​ | % |
Revenue | ​ | $ | 10,553 | ​ | $ | 9,733 | ​ | $ | 820 | ​ | 8 | %
Cost of revenue | ​ |  | 2,301 | ​ | ​ | 1,995 | ​ | ​ | 306 | ​ | 15 | %
Gross profit | ​ |  | 8,252 | ​ | ​ | 7,738 | ​ | ​ | 514 | ​ | 7 | %
Operating expenses: | ​ |  | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Selling and marketing | ​ |  | 3,852 | ​ | ​ | 3,714 | ​ | ​ | 138 | ​ | 4 | %
Research and development | ​ |  | 1,110 | ​ | ​ | 1,153 | ​ | ​ | (43) | ​ | (4) | %
General and administrative | ​ |  | 5,173 | ​ | ​ | 3,761 | ​ | ​ | 1,412 | ​ | 38 | %
Change in fair value of contingent consideration | ​ |  | — | ​ | ​ | 50 | ​ | ​ | (50) | ​ | (100) | %
Total operating expenses | ​ |  | 10,135 | ​ | ​ | 8,678 | ​ | ​ | 1,457 | ​ | 17 | %
Operating loss | ​ |  | (1,883) | ​ | ​ | (940) | ​ | ​ | (943) | ​ | 100 | %
Other expense: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Interest expense, net | ​ |  | (231) | ​ | ​ | (229) | ​ | ​ | (2) | ​ | 1 | %
Loss on extinguishment of debt | ​ | ​ | — | ​ | ​ | (300) | ​ | ​ | 300 | ​ | (100) | %
Total other expense | ​ | ​ | (231) | ​ | ​ | (529) | ​ | ​ | 298 | ​ | (56) | %
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net loss | ​ | $ | (2,114) | ​ | $ | (1,469) | ​ | $ | (645) | ​ | 44 | %

​

Revenue

The following table presents our revenues disaggregated by sales channel:

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ ​ ​ | Three months ended March 31, | ​ ​ ​ | Change |
(in thousands) |  | 2026 | ​ ​ ​ | 2025 | ​ ​ | $ | ​ ​ ​ | % | ​
Partner and Marketplace | ​ | $ | 5,971 | ​ | $ | 5,520 | ​ | $ | 451 | ​ | 8 | %
Enterprise | ​ |  | 4,582 | ​ | ​ | 4,213 | ​ | ​ | 369 | ​ | 9 | %
Total revenues | ​ | $ | 10,553 | ​ | $ | 9,733 | ​ | $ | 820 | ​ | 8 | %

​

The Partner and Marketplace channel consists of our Content Management System (“CMS”) partners, platform & agency partners, authorized resellers and the Marketplace. This channel serves small and medium sized businesses that are on a partner or reseller’s web-hosting platform or that purchase our solutions from our Marketplace.

​

The Enterprise channel consists of our larger customers and organizations, including those with non-platform custom websites, who generally engage directly with AudioEye sales personnel for custom pricing and solutions. This channel also includes federal, state and local government agencies.

​

For the three months ended March 31, 2026, total revenue increased by 8% over the prior year comparable period. The 8% increase in Partner and Marketplace channel revenue for the three months ended March 31, 2026 was primarily due to continued expansion with

17

Table of Contents

existing partners. The 9% increase in Enterprise channel revenue for the three months ended March 31, 2026 was driven primarily by new customer relationships, including additions from acquisitions.

​

Cost of Revenue and Gross Profit

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three months ended March 31, | ​ ​ ​ | Change |
(in thousands) | ​ ​ ​ | 2026 | ​ ​ ​ | 2025 | ​ ​ ​ | $ | ​ ​ ​ | % |
Revenue | ​ | $ | 10,553 | ​ | $ | 9,733 | ​ | $ | 820 | ​ | 8 | %
Cost of Revenue | ​ |  | 2,301 | ​ | ​ | 1,995 | ​ | ​ | 306 | ​ | 15 | %
Gross profit | ​ | $ | 8,252 | ​ | $ | 7,738 | ​ | $ | 514 | ​ | 7 | %

​

Cost of revenue consists primarily of compensation and related benefits costs for our customer experience team, as well as a portion of our technology operations team that supports the delivery of our services, fees paid to our managed hosting and other third-party service providers, amortization of capitalized software development costs and patent costs, and allocated overhead costs.

For the three months ended March 31, 2026, cost of revenue increased by 15% over the prior year comparable period. The increase in cost of revenue was primarily due to higher costs incurred for service delivery supporting our increased revenue, additional costs attributable to asset acquisitions, and higher amortization expense related to our capitalized software development costs.

For the three months ended March 31, 2026, gross profit increased by 7% over the prior year comparable periods. The increase in gross profit was a result of increased revenue from new customers exceeding the incremental fulfilment cost.

Selling and Marketing Expenses

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ ​ ​ | Three months ended March 31, | ​ ​ ​ | Change |
(in thousands) | ​ ​ ​ | 2026 | ​ ​ ​ | 2025 | ​ ​ ​ | $ | ​ ​ ​ | % |
Selling and marketing | ​ | $ | 3,852 | ​ | $ | 3,714 | ​ | $ | 138 | ​ | 4 | %

​

Selling and marketing expenses consist primarily of compensation and benefits related to our sales and marketing staff, as well as third-party advertising and marketing expenses.

For the three months ended March 31, 2026, selling and marketing expenses increased by 4% over the prior year comparable period. The increase in selling and marketing expenses resulted primarily from higher third-party marketing expenses and personnel costs.

Research and Development Expenses

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ ​ ​ | Three months ended March 31, | ​ ​ ​ | Change |
(in thousands) | ​ ​ ​ | 2026 | ​ ​ ​ | 2025 | ​ ​ ​ | $ | ​ ​ ​ | % |
Research and development expense | ​ | $ | 1,110 | ​ | $ | 1,153 | ​ | $ | (43) | ​ | (4) | %
Plus: Capitalized research and development cost | ​ |  | 465 | ​ | ​ | 472 | ​ | ​ | (7) | ​ | (1) | %
Total research and development cost | ​ | $ | 1,575 | ​ | $ | 1,625 | ​ | $ | (50) | ​ | (3) | %

​

Research and development (“R&D”) expenses consist primarily of compensation and related benefits, independent contractor costs, and an allocated portion of general overhead costs related to our employees involved in research and development activities. Total research and development cost includes the amount of research and development expense reported within operating expenses as well as research and development cost that was capitalized during the fiscal period.

For the three months ended March 31, 2026, R&D expenses decreased by 4% from the prior year comparable period. The decrease was driven by lower personnel cost. For the three months ended March 31, 2026, capitalized R&D cost remained consistent with the prior year comparable period due to engineering personnel spending a similar level of effort on product development. For the three months ended March 31, 2026, total R&D cost, which includes both R&D expenses and capitalized R&D costs, decreased by 3% from the prior year comparable period.

​

18

Table of Contents

General and Administrative Expenses

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three months ended March 31, | ​ | Change |
(in thousands) | ​ ​ ​ | 2026 | ​ ​ ​ | 2025 | ​ ​ ​ | $ | ​ ​ ​ | % | ​
General and administrative | ​ | $ | 5,173 | ​ | $ | 3,761 | ​ | $ | 1,412 | ​ | 38 | %

​

General and administrative expenses consist primarily of compensation and benefits related to our executives, directors and corporate support functions, and general corporate expenses including legal fees, occupancy and transaction costs.

For the three months ended March 31, 2026, general and administrative expenses increased by 38% from the prior year comparable period. The increase in general and administrative expense was due primarily to an increase in litigation expense by $1,110,000, as well as to higher stock compensation expense and amortization expense associated with our intangible assets.

Change in Fair Value of Contingent Consideration

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three months ended March 31, | ​ | Change |
(in thousands) | ​ ​ ​ | 2026 | ​ ​ ​ | 2025 | ​ ​ ​ | $ | ​ ​ ​ | % | ​
Change in fair value of contingent consideration | ​ | $ | — | ​ | $ | 50 | ​ | $ | (50) | ​ | (100) | %

​

Change in fair value of contingent consideration consists of non-cash valuation adjustments to contingent consideration liabilities recognized in connection with the acquisition of ADA Site Compliance, which was accounted for as a business combination.

For the three months ended March 31, 2026, no change in fair value of contingent consideration was recorded. The earnout targets for ADA Site Compliance were measured as of December 31, 2025, and no further changes in the fair value of this contingent consideration are expected following that measurement date.

Interest Expense

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ ​ ​ | Three months ended March 31, | ​ ​ ​ | Change |
(in thousands) | ​ ​ ​ | 2026 | ​ ​ ​ | 2025 | ​ ​ ​ | $ | ​ ​ ​ | % |
Interest expense, net | ​ | $ | (231) | ​ | $ | (229) | ​ | $ | (2) | ​ | 1 | %

​

Interest expense, net consists primarily of interest on our term loan, offset by interest income from investment in money market funds.

For the three months ended March 31, 2026, interest expense, net remained consistent with the prior year comparable period, as the impact of the higher outstanding principal balance was mostly offset by the lower interest rate from the new credit facility and the increase in interest income from investment in money market funds.

Loss on Extinguishment of Debt

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ ​ ​ | Three months ended March 31, | ​ ​ ​ | Change |
(in thousands) | ​ ​ ​ | 2026 | ​ ​ ​ | 2025 | ​ ​ ​ | $ | ​ ​ ​ | % |
Loss on extinguishment of debt | ​ | $ | — | ​ | $ | (300) | ​ | $ | 300 | ​ | (100) | %

​

On March 31, 2025, upon entering into a new credit facility with Western Alliance Bank, the Company paid the full $7.0 million in outstanding principal on its previous term loan with SG Credit Partners. In the three months ended March 31, 2025, in connection with the termination of the SG Credit Partners term loan, we recognized a $300,000 loss on extinguishment of debt, which included prepayment and other fees and the unamortized portion of related debt discount and debt issuance costs.

Other Key Operating Metrics

We consider annual recurring revenue (“ARR”) as a key operating metric and a key indicator of our overall business. We also use ARR as one of the primary methods for planning and forecasting overall expectations and for evaluating, on at least a quarterly and annual basis, actual results against such expectations.

We define ARR as the sum of (i) for our Enterprise channel, the total of the annualized recurring fee at the date of determination under each active contract, plus (ii) for our Partner and Marketplace channel, the annual or monthly recurring fee for all active customers at

19

Table of Contents

the date of determination, in each case, assuming no changes to the subscription, multiplied by 12 if applicable. Recurring fees are defined as revenues expected to be generated from services typically offered as a subscription service or annual service offering such as our automation and platform, periodic auditing, human-assisted technological fixes, legal support and professional service offerings and other services that reoccur on a multi-year contract. This determination includes both annual and monthly contracts for recurring products. Some of our contracts are terminable prior to the expected term, which may impact future ARR. ARR excludes non-recurring fees, which are defined as revenue expected to be generated from services typically not offered as a subscription service or annual service offering such as our PDF remediation services business, one-time mobile application reports, and other miscellaneous services that are offered as non-subscription services or are expected to be one-time in nature. As of March 31, 2026, ARR was $41.2 million, which represents an increase of 11% year-over-year, driven by growth in both our Partner and Marketplace channel and Enterprise channel.

Liquidity and Capital Resources

Working Capital

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
(in thousands) | ​ | March 31, 2026 | ​ ​ ​ | December 31, 2025 | ​
Current assets | ​ | $ | 15,876 | ​ | $ | 12,622 | ​
Current liabilities | ​ |  | (15,436) | ​ |  | (14,416) | ​
Working capital | ​ | $ | 440 | ​ | $ | (1,794) | ​

​

As of March 31, 2026, we had $8,563,000 in cash and cash equivalents and working capital of $440,000. The $2.2 million increase in working capital in the three months ended March 31, 2026 was primarily due to $3.6 million in proceeds drawn from the remaining subsequent term loan advances available to the Company, partially offset by the increase in accrued expenses and in a portion of our term loan being classified as a current liability.

In January 2025, the Board of Directors adopted a share repurchase program authorizing the repurchase of up to $12.5 million of our common stock through January 24, 2027. The program may be amended, suspended, or discontinued at any time and does not commit the Company to repurchase any shares of its common stock. Shares repurchased under the program are subsequently retired and restored to the status of authorized but unissued shares of common stock. In the three months ended March 31, 2026, we used $475,000 of the program to repurchase shares. As of March 31, 2026, we had $7.45 million remaining for the repurchase of shares.

As of March 31, 2026, we had $17.0 million outstanding under the term loan, $16.2 million of which is classified as a noncurrent liability. The term loan matures on March 31, 2030, and requires quarterly principal payments beginning on April 10, 2026. Refer to Note 3 – Debt to our consolidated financial statements for additional information regarding our credit facility.

As of May 12, 2026, we had no off-balance sheet arrangements, and we believe that the Company has sufficient liquidity to continue as a going concern through the next twelve months.

While the Company has been successful in raising capital, there is no assurance that it will be successful at raising additional capital in the future. Additionally, if the Company’s plans are not achieved and/or if significant unanticipated events occur, the Company may have to further modify its business plan, which may require us to raise additional capital or reduce expenses.

​

Cash Flows

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three months ended March 31, | ​
(in thousands) | ​ ​ ​ | 2026 | ​ ​ ​ | 2025 | ​
Net cash provided by (used in) operating activities | ​ ​ ​ | $ | 1,260 | ​ | $ | (44) | ​
Net cash used in investing activities | ​ |  | (727) | ​ |  | (790) | ​
Net cash provided by financing activities | ​ |  | 2,742 | ​ |  | 3,448 | ​
Net increase in cash and cash equivalents | ​ | $ | 3,275 | ​ | $ | 2,614 | ​

​

For the three months ended March 31, 2026, in relation to the prior year comparable period, cash provided by operating activities increased primarily due to timing of payments and the increase in revenue.

​

20

Table of Contents

For the three months ended March 31, 2026, in relation to the prior year comparable period, cash used in investing activities decreased primarily due to a reduction in payments associated acquisitions in the current year period.

For the three months ended March 31, 2026, in relation to the prior year comparable period, cash provided by financing activities decreased primarily due to $475,000 in stock repurchases in the first quarter of 2026, as well as to lower net proceeds from credit facility activity. In the three months ended March 31, 2026 and 2025, we obtained $3.6 million and $12.0 million, respectively, in proceeds from term loan borrowings under the credit facility with Western Alliance Bank. In the three months ended March 31, 2025, we used a portion of the term loan borrowings to repay our previous $7.0 million term loan, as well as costs associated with the issuance and termination of our previous credit facilities.

Critical Accounting Policies and Estimates

The discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with the accounting principles generally accepted in the United States. The preparation of consolidated financial statements requires management to make estimates and assumptions that affect the amounts reported and disclosed in our consolidated financial statements and the accompanying notes. Actual results could differ materially from these estimates under different assumptions or conditions.

​

Our critical accounting estimates, as described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, relate to contingent consideration recognized in connection with business combinations and asset acquisitions. There have been no material changes to our critical accounting policies and estimates as disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.

​

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Not applicable.

​

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

The Company maintains disclosure controls and procedures that are designed to ensure that there is reasonable assurance that the information required to be disclosed in the Company’s reports under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to the Company’s management, including its Principal Executive Officer and Principal Financial Officer, as appropriate, to allow timely decisions regarding required disclosure based on the definition of “disclosure controls and procedures” in Exchange Act Rules 13a-15(e) and 15d-15(e). In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. In addition, projections of any evaluation of effectiveness of our disclosure controls and procedures to future periods are subject to the risk that controls or procedures may become inadequate because of changes in conditions, or that the degree of compliance with the controls or procedures may deteriorate.

As of the end of the period covered by this report, an evaluation was performed under the supervision and with the participation of the Company’s senior management, including the Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer), of the effectiveness of the design and operation of the Company’s disclosure controls and procedures to provide reasonable assurance of achieving the desired objectives of the disclosure controls and procedures. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer has concluded that our disclosure controls and procedures were effective as of March 31, 2026.

Changes in Internal Controls over Financial Reporting

During the quarter ended March 31, 2026, there were no changes in our internal control over financial reporting that have materially affected, or that are reasonably likely to materially affect, our internal control over financial reporting.

21

Table of Contents

​

PART II — OTHER INFORMATION

Item 1. Legal Proceedings

We may become involved in various routine disputes and allegations incidental to our business operations. While it is not possible to determine the ultimate disposition of these matters, our management believes that the resolution of any such matters, should they arise, is not likely to have a material adverse effect on our financial position or results of operations.

​

Item 1A. Risk Factors

You should carefully consider the factors discussed in Part I, Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025 (“2025 Form 10-K”), which could materially affect our business, financial condition and results of operations. There have been no material changes to the risk factors set forth in the 2025 Form 10-K. The risks described in our 2025 Form 10-K are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or results of operations.

​

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following table sets forth information with respect to our repurchases of common stock during the three months ended March 31, 2026:

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ ​ ​ | ​ | ​ | ​ ​ ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Maximum Number (or
​ | ​ | ​ | ​ | ​ | ​ | ​ | Total Number of | ​ | Approximate Dollar
​ | ​ | ​ | ​ | ​ | ​ | ​ | Shares Purchased | ​ | Value) of Shares that
​ | ​ | ​ | ​ | ​ | ​ | ​ | as Part of Publicly | ​ | May Yet Be Purchased
​ | ​ | Total Number of | ​ | Average Price | ​ | Announced Plans or | ​ | under the Plans or
Period | ​ ​ ​ | Shares Purchased | ​ ​ ​ | Paid per Share | ​ ​ ​ | Programs | ​ ​ ​ | Programs (2)
January 1 - January 31, 2026: |  | ​ | ​ | ​ | ​ |  | ​ | ​ |  | ​
Employee transactions (1) |  | 33,188 | ​ | $ | 9.49 |  | — | ​ | $ | —
February 1 - February 28, 2026: |  | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Employee transactions (1) |  | 3,556 | ​ | ​ | 6.83 |  | — | ​ |  | —
March 1 - March 31, 2026: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Employee transactions (1) | ​ | 7,246 | ​ | ​ | 5.93 | ​ | — | ​ | ​ | —
Share repurchase program (2) | ​ | 82,200 | ​ | ​ | 5.78 | ​ | 82,200 | ​ | ​ | 7,450,000
Total: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Employee transactions (1) | ​ | 43,990 | ​ | $ | 8.69 | ​ | — | ​ | $ | —
Share repurchase program (2) | ​ | 82,200 | ​ | $ | 5.78 | ​ | 82,200 | ​ | $ | 7,450,000

| (1) | Consists of shares surrendered by employees to satisfy tax withholding obligations in connection with the settlement of restricted stock units.

| (2) | In January 2025, the Board of Directors adopted a share repurchase program authorizing the repurchase of up to $12.5 million of our common stock through January 24, 2027. Shares repurchased under the program will be subsequently retired. The average price paid per share includes any broker fees.

​

22

Table of Contents

Item 5. Other Information

​
Rule 10b5-1 Trading Plans

​

On March 12, 2026, Sero Capital LLC, an entity whose Chief Executive Officer and beneficial owner is David Moradi, the Company’s Executive Chairman and Chief Product Officer, terminated a pre-arranged trading plan that was intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act. The arrangement, originally adopted on May 30, 2025, covered the sale of up to 500,000 shares of common stock and was scheduled to expire on May 29, 2026.

​

On March 23, 2026, Kelly Georgevich, the Company’s Chief Executive Officer and Chief Financial Officer, terminated a pre-arranged trading plan that was intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act. The arrangement, originally adopted on June 9, 2025, covered the sale of up to 20,000 shares of common stock and was scheduled to expire on September 9, 2026.

​

23

Table of Contents

​

Item 6. Exhibits

​

​ | ​ ​ ​ | ​ | Incorporation by Reference
Exhibit No. | ​ ​ ​ | Description | ​ ​ ​ | Form | ​ ​ ​ | Date of Filing | ​ ​ ​ | Exhibit No. | ​ ​ ​ | Filed Herewith
3.1 | ​ | Restated Certificate of Incorporation of AudioEye, Inc., dated as of May 24, 2024 | ​ | 8-K | ​ | May 24, 2024 | ​ | 3.3 | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
3.2 | ​ | By-Laws of AudioEye, Inc. (as amended as of May 22, 2024) | ​ | 10-Q | ​ | July 29, 2024 | ​ | 3.3 | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
10.1 | ​ | Consent and Third Loan Modification Agreement, dated as of January 12, 2026, by and among Western Alliance Bank, AudioEye, Inc., ADA Site Compliance, LLC and Criterion 508 Solutions, Inc. | ​ | 10-K | ​ | March 12, 2026 | ​ | 10.24 | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
10.2 | ​ | Amended and Restated Employment Agreement, dated as of May 4, 2026, by and between AudioEye, Inc. and Kelly Georgevich | ​ | 8-K | ​ | May 7, 2026 | ​ | 10.1 | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
10.3 | ​ | Second Amended and Restated Employment Agreement, dated as of May 4, 2026, by and between AudioEye, Inc. and David Moradi | ​ | 8-K | ​ | May 7, 2026 | ​ | 10.2 | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
31.1 | ​ | Certification of the Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | X
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
32.1 | ​ | Certification of the Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | X
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
101.INS | ​ | Inline XBRL Instance Document | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
101.SCH | ​ | Inline XBRL Taxonomy Extension Schema Document | ​ | ​ | ​ | ​ | ​ | ​ | ​ | X
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
101.CAL | ​ | Inline XBRL Taxonomy Extension Calculation Linkbase Document | ​ | ​ | ​ | ​ | ​ | ​ | ​ | X
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
101.DEF | ​ | Inline XBRL Taxonomy Extension Definition Linkbase Document | ​ | ​ | ​ | ​ | ​ | ​ | ​ | X
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
101.LAB | ​ | Inline XBRL Taxonomy Extension Label Linkbase Document | ​ | ​ | ​ | ​ | ​ | ​ | ​ | X
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
101.PRE | ​ | Inline XBRL Taxonomy Extension Presentation Linkbase Document | ​ | ​ | ​ | ​ | ​ | ​ | ​ | X
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
104 | ​ | Cover Page Interactive Data File - The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​

​

​

24

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

​

​ | ​ | ​ | AUDIOEYE, INC.
​ | ​ | ​ | ​ | ​
Date: | May 12, 2026 | ​ ​ ​ | By: | /s/ Kelly Georgevich
​ | ​ | ​ | ​ | Kelly Georgevich
​ | ​ | ​ | ​ | Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer
​ | ​ | ​ | ​ | ​

​

​

​

25